LCI may have a role in the routine clinical care of both adult and pediatric CF patients as a good tool to assess response to IV antibiotic end-therapy in the same way as FEV1.
Keyphrases
- cystic fibrosis
- healthcare
- newly diagnosed
- ejection fraction
- chronic obstructive pulmonary disease
- pseudomonas aeruginosa
- palliative care
- pulmonary hypertension
- prognostic factors
- lung function
- patient reported outcomes
- quality improvement
- intensive care unit
- pain management
- chronic pain
- cell therapy
- patient reported
- childhood cancer
- replacement therapy